nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—NR1H4—bile—colon cancer	0.138	0.424	CbGeAlD
Chenodeoxycholic acid—NR1H4—gall bladder—colon cancer	0.0384	0.118	CbGeAlD
Chenodeoxycholic acid—NR1H4—renal system—colon cancer	0.0184	0.0564	CbGeAlD
Chenodeoxycholic acid—NR1H4—digestive system—colon cancer	0.0151	0.0463	CbGeAlD
Chenodeoxycholic acid—CYP27A1—renal system—colon cancer	0.0134	0.0411	CbGeAlD
Chenodeoxycholic acid—UGT2B7—renal system—colon cancer	0.0119	0.0364	CbGeAlD
Chenodeoxycholic acid—NR1H4—liver—colon cancer	0.0112	0.0345	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lymphoid tissue—colon cancer	0.0111	0.0341	CbGeAlD
Chenodeoxycholic acid—CYP27A1—digestive system—colon cancer	0.011	0.0337	CbGeAlD
Chenodeoxycholic acid—UGT2B7—digestive system—colon cancer	0.00973	0.0298	CbGeAlD
Chenodeoxycholic acid—CYP27A1—vagina—colon cancer	0.00971	0.0297	CbGeAlD
Chenodeoxycholic acid—NR1H4—lymph node—colon cancer	0.00862	0.0264	CbGeAlD
Chenodeoxycholic acid—CYP27A1—liver—colon cancer	0.00819	0.0251	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CHST4—colon cancer	0.00742	0.14	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—liver—colon cancer	0.00725	0.0222	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lymph node—colon cancer	0.00628	0.0192	CbGeAlD
Chenodeoxycholic acid—UGT2B7—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00484	0.0914	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00425	0.0802	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CHST5—colon cancer	0.00341	0.0643	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CHST4—colon cancer	0.00338	0.0638	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—renal system—colon cancer	0.00323	0.00991	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00283	0.0534	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—digestive system—colon cancer	0.00265	0.00812	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00244	0.0461	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.0021	0.0397	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—liver—colon cancer	0.00198	0.00605	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.0017	0.0321	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CHST5—colon cancer	0.00155	0.0293	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00123	0.0232	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.0012	0.0226	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00111	0.021	CbGpPWpGaD
Chenodeoxycholic acid—Jaundice—Capecitabine—colon cancer	0.00111	0.00178	CcSEcCtD
Chenodeoxycholic acid—Infection—Vincristine—colon cancer	0.0011	0.00178	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Capecitabine—colon cancer	0.0011	0.00178	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Capecitabine—colon cancer	0.0011	0.00178	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Fluorouracil—colon cancer	0.0011	0.00177	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Irinotecan—colon cancer	0.00109	0.00176	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Vincristine—colon cancer	0.00109	0.00176	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Vincristine—colon cancer	0.00109	0.00175	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Capecitabine—colon cancer	0.00108	0.00175	CcSEcCtD
Chenodeoxycholic acid—Oedema—Irinotecan—colon cancer	0.00108	0.00174	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Fluorouracil—colon cancer	0.00108	0.00174	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Fluorouracil—colon cancer	0.00108	0.00174	CcSEcCtD
Chenodeoxycholic acid—Infection—Irinotecan—colon cancer	0.00108	0.00173	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Vincristine—colon cancer	0.00107	0.00173	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Capecitabine—colon cancer	0.00107	0.00173	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Capecitabine—colon cancer	0.00107	0.00173	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Fluorouracil—colon cancer	0.00107	0.00172	CcSEcCtD
Chenodeoxycholic acid—Shock—Irinotecan—colon cancer	0.00107	0.00172	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Irinotecan—colon cancer	0.00106	0.00171	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Irinotecan—colon cancer	0.00106	0.00171	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Vincristine—colon cancer	0.00106	0.00171	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Irinotecan—colon cancer	0.00105	0.00169	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Fluorouracil—colon cancer	0.00105	0.00168	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Vincristine—colon cancer	0.00104	0.00167	CcSEcCtD
Chenodeoxycholic acid—Oedema—Fluorouracil—colon cancer	0.00104	0.00167	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Irinotecan—colon cancer	0.00103	0.00166	CcSEcCtD
Chenodeoxycholic acid—Infection—Fluorouracil—colon cancer	0.00103	0.00166	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Capecitabine—colon cancer	0.00103	0.00165	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Capecitabine—colon cancer	0.00102	0.00165	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Capecitabine—colon cancer	0.00102	0.00164	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Fluorouracil—colon cancer	0.00102	0.00164	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Fluorouracil—colon cancer	0.00102	0.00164	CcSEcCtD
Chenodeoxycholic acid—Liver function test abnormal—Methotrexate—colon cancer	0.00101	0.00163	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Vincristine—colon cancer	0.00101	0.00163	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Capecitabine—colon cancer	0.00101	0.00163	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Fluorouracil—colon cancer	0.00101	0.00163	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Irinotecan—colon cancer	0.00101	0.00163	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Capecitabine—colon cancer	0.00101	0.00162	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Vincristine—colon cancer	0.00101	0.00162	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Capecitabine—colon cancer	0.001	0.00162	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Capecitabine—colon cancer	0.001	0.00161	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Capecitabine—colon cancer	0.001	0.00161	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Vincristine—colon cancer	0.000998	0.00161	CcSEcCtD
Chenodeoxycholic acid—Breast disorder—Methotrexate—colon cancer	0.000992	0.0016	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Fluorouracil—colon cancer	0.000988	0.00159	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Capecitabine—colon cancer	0.000983	0.00158	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Irinotecan—colon cancer	0.000979	0.00158	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CA7—colon cancer	0.000975	0.0184	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Irinotecan—colon cancer	0.000972	0.00157	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Fluorouracil—colon cancer	0.000969	0.00156	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Vincristine—colon cancer	0.000966	0.00156	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Irinotecan—colon cancer	0.000965	0.00156	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Irinotecan—colon cancer	0.000962	0.00155	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Vincristine—colon cancer	0.00096	0.00155	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Vincristine—colon cancer	0.000958	0.00154	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Capecitabine—colon cancer	0.000953	0.00154	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Irinotecan—colon cancer	0.000953	0.00154	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Capecitabine—colon cancer	0.000951	0.00153	CcSEcCtD
Chenodeoxycholic acid—Constipation—Vincristine—colon cancer	0.000951	0.00153	CcSEcCtD
Chenodeoxycholic acid—Pain—Vincristine—colon cancer	0.000951	0.00153	CcSEcCtD
Chenodeoxycholic acid—Asthma—Methotrexate—colon cancer	0.000949	0.00153	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Capecitabine—colon cancer	0.000947	0.00152	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000945	0.00152	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Irinotecan—colon cancer	0.000941	0.00152	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Fluorouracil—colon cancer	0.000938	0.00151	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.000935	0.00151	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Irinotecan—colon cancer	0.000933	0.0015	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Fluorouracil—colon cancer	0.000931	0.0015	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Methotrexate—colon cancer	0.00093	0.0015	CcSEcCtD
Chenodeoxycholic acid—Pain—Irinotecan—colon cancer	0.000926	0.00149	CcSEcCtD
Chenodeoxycholic acid—Constipation—Irinotecan—colon cancer	0.000926	0.00149	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Capecitabine—colon cancer	0.000925	0.00149	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Fluorouracil—colon cancer	0.000924	0.00149	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Fluorouracil—colon cancer	0.000922	0.00149	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Capecitabine—colon cancer	0.000921	0.00148	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Capecitabine—colon cancer	0.000919	0.00148	CcSEcCtD
Chenodeoxycholic acid—Chills—Capecitabine—colon cancer	0.000915	0.00147	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Fluorouracil—colon cancer	0.000913	0.00147	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Capecitabine—colon cancer	0.000911	0.00147	CcSEcCtD
Chenodeoxycholic acid—Abdominal discomfort—Methotrexate—colon cancer	0.000909	0.00147	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Vincristine—colon cancer	0.000909	0.00146	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Fluorouracil—colon cancer	0.000901	0.00145	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Capecitabine—colon cancer	0.000901	0.00145	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000895	0.00144	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Irinotecan—colon cancer	0.000892	0.00144	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Capecitabine—colon cancer	0.000888	0.00143	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Methotrexate—colon cancer	0.000887	0.00143	CcSEcCtD
Chenodeoxycholic acid—Pain—Fluorouracil—colon cancer	0.000887	0.00143	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Irinotecan—colon cancer	0.000885	0.00143	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Methotrexate—colon cancer	0.000882	0.00142	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Vincristine—colon cancer	0.000879	0.00142	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Vincristine—colon cancer	0.000879	0.00142	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Capecitabine—colon cancer	0.000875	0.00141	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Methotrexate—colon cancer	0.000866	0.00139	CcSEcCtD
Chenodeoxycholic acid—Back pain—Capecitabine—colon cancer	0.000859	0.00138	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Irinotecan—colon cancer	0.000856	0.00138	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Irinotecan—colon cancer	0.000856	0.00138	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Fluorouracil—colon cancer	0.000854	0.00138	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Capecitabine—colon cancer	0.000854	0.00138	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Methotrexate—colon cancer	0.000851	0.00137	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Methotrexate—colon cancer	0.000846	0.00136	CcSEcCtD
Chenodeoxycholic acid—Infestation—Methotrexate—colon cancer	0.000846	0.00136	CcSEcCtD
Chenodeoxycholic acid—Depression—Methotrexate—colon cancer	0.000843	0.00136	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Methotrexate—colon cancer	0.000831	0.00134	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Capecitabine—colon cancer	0.000824	0.00133	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Fluorouracil—colon cancer	0.000824	0.00133	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Methotrexate—colon cancer	0.000822	0.00132	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Capecitabine—colon cancer	0.000821	0.00132	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Fluorouracil—colon cancer	0.00082	0.00132	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Vincristine—colon cancer	0.000819	0.00132	CcSEcCtD
Chenodeoxycholic acid—Sweating—Methotrexate—colon cancer	0.000811	0.00131	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Methotrexate—colon cancer	0.000806	0.0013	CcSEcCtD
Chenodeoxycholic acid—Malaise—Capecitabine—colon cancer	0.000801	0.00129	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Methotrexate—colon cancer	0.0008	0.00129	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Methotrexate—colon cancer	0.000798	0.00129	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Capecitabine—colon cancer	0.000798	0.00129	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Irinotecan—colon cancer	0.000798	0.00129	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Vincristine—colon cancer	0.000798	0.00129	CcSEcCtD
Chenodeoxycholic acid—Syncope—Capecitabine—colon cancer	0.000796	0.00128	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Capecitabine—colon cancer	0.000795	0.00128	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Capecitabine—colon cancer	0.000785	0.00126	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Capecitabine—colon cancer	0.00078	0.00126	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Irinotecan—colon cancer	0.000777	0.00125	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000776	0.0147	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Capecitabine—colon cancer	0.000775	0.00125	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Capecitabine—colon cancer	0.000767	0.00123	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Fluorouracil—colon cancer	0.000764	0.00123	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Methotrexate—colon cancer	0.000763	0.00123	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Vincristine—colon cancer	0.000761	0.00123	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Methotrexate—colon cancer	0.000759	0.00122	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Capecitabine—colon cancer	0.000756	0.00122	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Capecitabine—colon cancer	0.000756	0.00122	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Capecitabine—colon cancer	0.000756	0.00122	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Methotrexate—colon cancer	0.000754	0.00121	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000751	0.00121	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Methotrexate—colon cancer	0.00075	0.00121	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Capecitabine—colon cancer	0.000747	0.0012	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Methotrexate—colon cancer	0.000744	0.0012	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Irinotecan—colon cancer	0.000741	0.00119	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Capecitabine—colon cancer	0.000739	0.00119	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Vincristine—colon cancer	0.000735	0.00118	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Fluorouracil—colon cancer	0.000734	0.00118	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Methotrexate—colon cancer	0.000732	0.00118	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Capecitabine—colon cancer	0.000731	0.00118	CcSEcCtD
Chenodeoxycholic acid—Oedema—Capecitabine—colon cancer	0.000725	0.00117	CcSEcCtD
Chenodeoxycholic acid—Infection—Capecitabine—colon cancer	0.00072	0.00116	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Irinotecan—colon cancer	0.000716	0.00115	CcSEcCtD
Chenodeoxycholic acid—Shock—Capecitabine—colon cancer	0.000713	0.00115	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CA7—colon cancer	0.000712	0.0135	CbGpPWpGaD
Chenodeoxycholic acid—Nervous system disorder—Capecitabine—colon cancer	0.000711	0.00114	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Methotrexate—colon cancer	0.00071	0.00114	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Fluorouracil—colon cancer	0.000709	0.00114	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Capecitabine—colon cancer	0.000709	0.00114	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Methotrexate—colon cancer	0.000708	0.00114	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Capecitabine—colon cancer	0.000707	0.00114	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Vincristine—colon cancer	0.000707	0.00114	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Methotrexate—colon cancer	0.000705	0.00114	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Capecitabine—colon cancer	0.000704	0.00113	CcSEcCtD
Chenodeoxycholic acid—Rash—Vincristine—colon cancer	0.000701	0.00113	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Capecitabine—colon cancer	0.000701	0.00113	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Vincristine—colon cancer	0.0007	0.00113	CcSEcCtD
Chenodeoxycholic acid—Headache—Vincristine—colon cancer	0.000696	0.00112	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Capecitabine—colon cancer	0.000691	0.00111	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Methotrexate—colon cancer	0.000689	0.00111	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Irinotecan—colon cancer	0.000688	0.00111	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Methotrexate—colon cancer	0.000686	0.0011	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Fluorouracil—colon cancer	0.000686	0.0011	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Methotrexate—colon cancer	0.000684	0.0011	CcSEcCtD
Chenodeoxycholic acid—Rash—Irinotecan—colon cancer	0.000683	0.0011	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Irinotecan—colon cancer	0.000682	0.0011	CcSEcCtD
Chenodeoxycholic acid—Chills—Methotrexate—colon cancer	0.000681	0.0011	CcSEcCtD
Chenodeoxycholic acid—Headache—Irinotecan—colon cancer	0.000678	0.00109	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Capecitabine—colon cancer	0.000677	0.00109	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Methotrexate—colon cancer	0.000671	0.00108	CcSEcCtD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—PPARG—colon cancer	0.000663	0.0125	CbGpPWpGaD
Chenodeoxycholic acid—Malnutrition—Methotrexate—colon cancer	0.000661	0.00106	CcSEcCtD
Chenodeoxycholic acid—Nausea—Vincristine—colon cancer	0.00066	0.00106	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00066	0.00106	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Fluorouracil—colon cancer	0.000659	0.00106	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Capecitabine—colon cancer	0.000655	0.00106	CcSEcCtD
Chenodeoxycholic acid—Rash—Fluorouracil—colon cancer	0.000654	0.00105	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Fluorouracil—colon cancer	0.000653	0.00105	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Capecitabine—colon cancer	0.000651	0.00105	CcSEcCtD
Chenodeoxycholic acid—Headache—Fluorouracil—colon cancer	0.00065	0.00105	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.000649	0.0123	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Capecitabine—colon cancer	0.000646	0.00104	CcSEcCtD
Chenodeoxycholic acid—Nausea—Irinotecan—colon cancer	0.000643	0.00104	CcSEcCtD
Chenodeoxycholic acid—Back pain—Methotrexate—colon cancer	0.000639	0.00103	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Capecitabine—colon cancer	0.000638	0.00103	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Capecitabine—colon cancer	0.00063	0.00101	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000626	0.00101	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Capecitabine—colon cancer	0.000625	0.00101	CcSEcCtD
Chenodeoxycholic acid—Pain—Capecitabine—colon cancer	0.00062	0.000998	CcSEcCtD
Chenodeoxycholic acid—Constipation—Capecitabine—colon cancer	0.00062	0.000998	CcSEcCtD
Chenodeoxycholic acid—Nausea—Fluorouracil—colon cancer	0.000616	0.000992	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Methotrexate—colon cancer	0.000613	0.000988	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Methotrexate—colon cancer	0.000611	0.000984	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000608	0.0115	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Capecitabine—colon cancer	0.000597	0.000962	CcSEcCtD
Chenodeoxycholic acid—Malaise—Methotrexate—colon cancer	0.000596	0.00096	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Methotrexate—colon cancer	0.000594	0.000957	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Capecitabine—colon cancer	0.000593	0.000955	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Methotrexate—colon cancer	0.000592	0.000953	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CHST5—colon cancer	0.000591	0.0112	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ODC1—colon cancer	0.000591	0.0112	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Methotrexate—colon cancer	0.000577	0.000929	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Capecitabine—colon cancer	0.000576	0.000927	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Capecitabine—colon cancer	0.000573	0.000923	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Capecitabine—colon cancer	0.000573	0.000923	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Methotrexate—colon cancer	0.000573	0.000923	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Methotrexate—colon cancer	0.000563	0.000907	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Methotrexate—colon cancer	0.000563	0.000907	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Methotrexate—colon cancer	0.000563	0.000907	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000559	0.0009	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Methotrexate—colon cancer	0.000556	0.000896	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Methotrexate—colon cancer	0.000544	0.000876	CcSEcCtD
Chenodeoxycholic acid—Infection—Methotrexate—colon cancer	0.000536	0.000863	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Capecitabine—colon cancer	0.000534	0.00086	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Methotrexate—colon cancer	0.000529	0.000852	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Methotrexate—colon cancer	0.000528	0.000851	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Methotrexate—colon cancer	0.000524	0.000844	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Methotrexate—colon cancer	0.000521	0.00084	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Capecitabine—colon cancer	0.00052	0.000838	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Methotrexate—colon cancer	0.000514	0.000828	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Capecitabine—colon cancer	0.000513	0.000826	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000512	0.00967	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Methotrexate—colon cancer	0.000504	0.000812	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Capecitabine—colon cancer	0.000496	0.000799	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000491	0.000792	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—HNF4A—colon cancer	0.000488	0.00922	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Methotrexate—colon cancer	0.000488	0.000786	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methotrexate—colon cancer	0.000484	0.00078	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Methotrexate—colon cancer	0.000481	0.000775	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Methotrexate—colon cancer	0.00048	0.000773	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Capecitabine—colon cancer	0.000479	0.000772	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Methotrexate—colon cancer	0.000475	0.000765	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Methotrexate—colon cancer	0.000469	0.000755	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000466	0.00075	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methotrexate—colon cancer	0.000465	0.000749	CcSEcCtD
Chenodeoxycholic acid—Pain—Methotrexate—colon cancer	0.000461	0.000743	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Capecitabine—colon cancer	0.000461	0.000742	CcSEcCtD
Chenodeoxycholic acid—Rash—Capecitabine—colon cancer	0.000457	0.000736	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Capecitabine—colon cancer	0.000456	0.000735	CcSEcCtD
Chenodeoxycholic acid—Headache—Capecitabine—colon cancer	0.000454	0.000731	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000447	0.00845	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Methotrexate—colon cancer	0.000445	0.000716	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA7—colon cancer	0.000444	0.00838	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Methotrexate—colon cancer	0.000441	0.000711	CcSEcCtD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—EP300—colon cancer	0.000434	0.0082	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CHST5—colon cancer	0.000432	0.00815	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ODC1—colon cancer	0.000432	0.00815	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Capecitabine—colon cancer	0.00043	0.000693	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Methotrexate—colon cancer	0.000429	0.00069	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Methotrexate—colon cancer	0.000426	0.000687	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methotrexate—colon cancer	0.000426	0.000687	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000425	0.00802	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Methotrexate—colon cancer	0.000397	0.00064	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Methotrexate—colon cancer	0.000387	0.000624	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Methotrexate—colon cancer	0.000382	0.000615	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Methotrexate—colon cancer	0.000369	0.000595	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000367	0.00692	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Methotrexate—colon cancer	0.000357	0.000575	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000356	0.00673	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000349	0.00659	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Methotrexate—colon cancer	0.000343	0.000553	CcSEcCtD
Chenodeoxycholic acid—Rash—Methotrexate—colon cancer	0.00034	0.000548	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methotrexate—colon cancer	0.00034	0.000547	CcSEcCtD
Chenodeoxycholic acid—Headache—Methotrexate—colon cancer	0.000338	0.000544	CcSEcCtD
Chenodeoxycholic acid—Nausea—Methotrexate—colon cancer	0.00032	0.000516	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000293	0.00553	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CHST5—colon cancer	0.000269	0.00508	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ODC1—colon cancer	0.000269	0.00508	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000244	0.0046	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000243	0.0046	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000243	0.00459	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HNF4A—colon cancer	0.000235	0.00444	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—colon cancer	0.000212	0.004	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000192	0.00362	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFB1—colon cancer	0.000187	0.00354	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000178	0.00336	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.00016	0.00301	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ABCB1—colon cancer	0.000156	0.00295	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—TYMS—colon cancer	0.000153	0.00289	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.00014	0.00265	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—colon cancer	0.000121	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000118	0.00223	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000117	0.0022	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ABCB1—colon cancer	0.000114	0.00215	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TYMS—colon cancer	0.000112	0.00212	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARG—colon cancer	0.000109	0.00205	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARG—colon cancer	0.000102	0.00193	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA7—colon cancer	0.000102	0.00193	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.62e-05	0.00163	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—colon cancer	8.54e-05	0.00161	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARG—colon cancer	7.93e-05	0.0015	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCB1—colon cancer	7.11e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EP300—colon cancer	7.1e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TYMS—colon cancer	6.98e-05	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—colon cancer	6.24e-05	0.00118	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CHST5—colon cancer	6.18e-05	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ODC1—colon cancer	6.18e-05	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—colon cancer	5.82e-05	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—colon cancer	5.25e-05	0.000992	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—EP300—colon cancer	5.19e-05	0.00098	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARG—colon cancer	4.95e-05	0.000934	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—colon cancer	4.29e-05	0.000811	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—colon cancer	4.03e-05	0.000762	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—colon cancer	3.89e-05	0.000735	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—colon cancer	3.84e-05	0.000725	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EP300—colon cancer	3.24e-05	0.000611	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—colon cancer	3.14e-05	0.000592	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—colon cancer	2.39e-05	0.000452	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—colon cancer	1.96e-05	0.000369	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCB1—colon cancer	1.63e-05	0.000308	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TYMS—colon cancer	1.6e-05	0.000303	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARG—colon cancer	1.14e-05	0.000214	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—colon cancer	8.93e-06	0.000169	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EP300—colon cancer	7.43e-06	0.00014	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—colon cancer	5.5e-06	0.000104	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—colon cancer	4.49e-06	8.48e-05	CbGpPWpGaD
